Entering text into the input field will update the search result below

TG Therapeutics price target lowered at Wainwright following FDA meeting on cancer therapy

Dec. 01, 2021 11:34 AM ETTG Therapeutics, Inc. (TGTX)By: Jonathan Block, SA News Editor3 Comments

Chronic myeloid leukemia cells or CML

jarun011/iStock via Getty Images

  • H.C. Wainwright has lowered its price target on TG Therapeutics (TGTX +4.9%) to $75 from $84 (~393% upside) after the company yesterday said that an FDA advisory committee would review its application for

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.